0002009791-24-000001.txt : 20240130 0002009791-24-000001.hdr.sgml : 20240130 20240130101903 ACCESSION NUMBER: 0002009791-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240130 DATE AS OF CHANGE: 20240130 EFFECTIVENESS DATE: 20240130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioNADrx Holdings, Inc. CENTRAL INDEX KEY: 0002009791 ORGANIZATION NAME: IRS NUMBER: 863213298 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-503839 FILM NUMBER: 24576262 BUSINESS ADDRESS: STREET 1: 207 N. BOONE STREET, SUITE 15 CITY: JOHNSON CITY STATE: TN ZIP: 37604 BUSINESS PHONE: (216) 470-3047 MAIL ADDRESS: STREET 1: 207 N. BOONE STREET, SUITE 15 CITY: JOHNSON CITY STATE: TN ZIP: 37604 D 1 primary_doc.xml X0708 D LIVE 0002009791 BioNADrx Holdings, Inc. 207 N. BOONE STREET, SUITE 15 JOHNSON CITY TN TENNESSEE 37604 (216) 470-3047 DELAWARE None None Corporation true 2021 Wendy Kormac 207 N. BOONE STREET, SUITE 15 JOHNSON CITY TN TENNESSEE 37604 Executive Officer Director Ms. Kormac is the chief executive officer and a director of the issuer. Filip Pinter 207 N. BOONE STREET, SUITE 15 JOHNSON CITY TN TENNESSEE 37604 Executive Officer Director Mr. Pinter is the chief financial officer and a director of the issuer. Phillip Mansour 207 N. BOONE STREET, SUITE 15 JOHNSON CITY TN TENNESSEE 37604 Director Biotechnology Decline to Disclose 06b false 2024-01-30 false true false 0 10000000 125000 9875000 false 1 0 0 0 false BioNADrx Holdings, Inc. /s/ Hunter C. Threet Hunter C. Threet Attorney for Issuer 2024-01-30